Background. Despite its importance, total body water (TBW) is usually estimated rather than measured due to the complexity of isotope dilution methods. The aim of this study was to demonstrate the applicability in haemodialysis (HD) patients of a recently developed on-line breath test, previously validated in healthy subjects, that uses the gold standard deuterium dilution method to measure TBW. In particular we wished to show that a pre-dialysis estimation was as good as a post-dialysis equilibrated measurement in order to avoid patients needing to remain behind after dialysis treatment. Methods. The dispersal kinetics of breath HDO, measured using a flowing afterglow mass spectrometer (FA-MS) following ingestion of D 2 O immediately post-dialysis, were determined in 12 haemodialysis patients and used to calculate the absolute TBW PostHD after full equilibration. TBW PreHD was then determined from breath samples taken immediately prior to the next dialysis. This measurement was adjusted for the interdialytic weight change and urine output (TBW PreHD-adjusted ) and compared to the TBW PostHD . The accuracy and precision of FA-MS was also assessed using known concentrations of deuterium-enriched water samples. Results. Mean TBW PostHD was 50.0 ± 9.3 L and TBW PreHD-adjusted was 50.7 ± 9.0 L. They were highly correlated (R = 0.99, P < 0.001) with a CV of 2.6%. The mean difference was +0.74 L (SEM 0.35, 95% CI −0.03 to 1.51 L, P = 0.059), compatible with a daily insensible loss of 0.37 L. Accuracy and precision of FA-MS were comparable to the previous validation work. Conclusions. This non-invasive adaptation of the D isotope dilution method for determining TBW can be applied -1782-620759; Email: simondavies1@compuserve.com to haemodialysis patients who show deuterium equilibration kinetics identical to normal subjects; a pre-dialysis estimation may be used to determine TBW, and so avoiding the necessity to remain behind after dialysis making this suitable for application in the clinical setting.
Introduction
Absolute measurement of total body water (TBW) is of value in tracking longitudinal body composition, fluid status and individualised dialysis dose in haemodialysis patients. Isotopic dilution studies are the gold standards of TBW measurement. However, due to the complexity of these techniques, specifically the laboratory quantification of isotopes in clinical samples, they are largely used for research only [1, 2] . The ideal TBW assessment method is that of a bedside, portable isotopic deuterium dilution method that allows reproducible TBW measurement in a clinical setting. To meet this challenge, we have developed a technique of TBW measurement using a flowing afterglow mass spectrometer (FA-MS) that can measure the D content of breath water vapour giving an immediate result from a sample obtained non-invasively. It is based on the principle of the deuterium dilution technique, which involves administering a dose of isotope to a subject, allowing the isotope to equilibrate within the dilution volume (in this case TBW) before the dilution volume is determined. The equilibration time for D dilution has been quoted to be between 4 and 6 h in previous studies [3] , although we have demonstrated that equilibration with breath in normal subjects is within 2 h [4] . This is another major limiting factor when applying such a conventional isotope dilution technique within a clinical setting, as most patients prefer not to extend their time in the dialysis unit.
A non-invasive, on-line deuterium dilution technique for the measurement of TBW in haemodialysis patients 2065 The main purpose of this study was to establish the agreement between TBW measured post-dialysis following the ingestion of D and to observe its full equilibration with body water over ∼2 h with the TBW measured predialysis at the subsequent dialysis session. If the agreement were sufficiently good, we can then rely on the pre-dialysis TBW measurement alone, negating the need for prolonged breath sampling to achieve equilibration after administrating the D 2 O. In addition, we wished to see if this approach to measuring TBW was acceptable to patients, to determine the subsequent clearance of D from the body and to re-validate the accuracy and precision of FA-MS in the measurement of known concentrations of D-enriched water samples.
Subjects and methods

Subjects
Twelve haemodialysis patients undergoing thrice weekly haemodialysis were selected for their variability in body composition. The average vintage of dialysis was 3.6 years (range from 0.6 to 16 years). Their demographics are summarised in Table 1 .
Principle of the flowing afterglow mass spectrometer
The flowing afterglow mass spectrometer is a prototype built by Trans Spectra Ltd, UK that underwent safety inspection by the hospital bioengineering department prior to its clinical use. The principle of FA-MS has been described previously [4, 5] Previous studies have shown that FA-MS can be used to measure deuterium in breath water vapour to a precision and accuracy of ∼1% [6] . The method has also been validated in normal subjects, compared with anthropometrics, and used successfully to track their body composition over 12 months [7, 8] . The technique has also been applied to the measurement of TBW and water transport across the peritoneum in peritoneal dialysis patients; in these studies the FA-MS method was able to accurately measure the addition of 2 L dialysate to the TBW [9] .
Study design
The protocol (see outline Figure 2 ) was approved by the local ethics committee and all patients gave their informed consent. Baseline breath samples were obtained on Day 1 of the study prior to the ingestion of D 2 O. Following the ingestion of a dose of D 2 O (0.3 g/kg of body weight; typically 25 mL), detailed dispersal kinetics and dialytic clearances of D 2 O were determined in all 12 patients. The exhaled breath was directly sampled and analysed at 5-min intervals until equilibration was achieved. It should be noted that the D 2 O quickly becomes HDO in excess water (H 2 O) via the process of rapid D/H exchange. The dose of D 2 O was chosen to give a predicted five-fold rise in the breath HDO level [9] for which FA-MS provides accurate measurements. Breath sampling was continued until equilibrium (a steady HDO value in breath) was reached. Baseline TBW postdialysis (TBW PostHD ) of the patient was calculated from the increase in breath HDO between equilibration and baseline (pre-ingestion) in relation to the volume of D 2 O ingested (Equation 1). Finally, the TBW values were reduced by 4% to account for the H-D exchange that occurs between the HDO with the carboxyl and amino groups in body proteins [2] .
Calculation of TBW:
where From the day of ingestion of D 2 O to the pre-dialysis study day, dilution of HDO within the body spaces will occur as the subject ingests fluid (measured by inter-dialytic weight changes). In addition, deuterium losses would also have occurred from sweating, respiration (insensible loss), and faecal (not measured) and urinary loss (measured as total urine output over 44 h). On the subsequent pre-dialysis day, breath samples were collected from the patients to calculate pre-haemodialysis TBW (TBW PreHD ). This second sampling procedure is shorter, taking only 10 to 15 min before dialysis. Therefore, the TBW PostHD is almost equivalent to TBW PreHD minus the total urine output (UO) and interdialytic weight changes ( W) plus insensible loss (IL) (Equation 2). When the TBW PreHD was adjusted for interdialytic weight changes and urine output, we termed this TBW PreHD-adjusted . By taking into account UO and interdialytic weight changes ( W), we expected that TBW PostHD would be highly correlated with TBW PreHD-adjusted :
where W = inter-dialytic weight changes, UO = total urine output in 44 h and IL = insensible loss.
To establish the rate of disappearance of D 2 O from the breath of dialysis patients, further breath samples were taken on subsequent dialysis days before and after dialysis. This enables us to calculate the rate of disappearance of breath, and thus body water HDO due to further dilution, insensible and urinary loss as well as due to dialysis treatment. The overall timing of breath samplings and TBW determination are summarised by the flow diagram in Figure 2 . • C in a water bath and the headspace vapour was sampled in triplicate (mean calculated to give each value) via a heated capillary using a 23G needle (Figure 1) . Two or three measurements of each of the deuterium-enriched water samples 156 to 750 ppm were performed over nine separate sessions to establish accuracy of the FA-MS instrument, see Figure 3 . Reproducibility between sessions was then calculated by taking 18 measurements of the 556 and 656 ppm samples (nine measurements each), chosen as these represent the range of concentrations of HDO achieved at equilibration level following ingestion of D 2 O.
Measurement of deuterium-enriched water samples to establish accuracy and reproducibility of FA-MS
Data acquisition and statistics
The D/H ratio was obtained using the FA-MS data acquisition programme (SCILIB library, version 4.96, 2005, Patrik Spanel, Trans Spectra Ltd, http://www.transspectra.com). Data normality was confirmed (Kolmogorov-Smirnov test). Data were presented as mean ± standard deviation (SD). Correlation between TBW PostHD and TBW PreHD-adjusted was assessed using Pearson's correlation coefficient. Coefficient of variance (CV) was used to assess variability. Paired t-tests were used to compare means. A Bland and Altman plot was applied to assess the agreement between TBW PostHD and TBW PreHD-adjusted . The accuracy of FA-MS was established by comparing the measured D/H measurements to the expected D/H values of the Denriched samples. The relationship of the measured to the expected value was investigated using Pearson's correlation. The paired Student t-test was also used to determine the differences between the expected to measured values. The agreement of the values was assessed using a Bland and Altman plot. The reproducibility of measurements was established by nine repeated analyses of the 556 and 656 ppm samples according to the coefficients of variation of these measurements. Statistical analyses were performed using the SPSS 14.0 statistical package (SPSS Inc., USA).
Results
Twelve patients completed the study. The data for one patient (patient 3) were excluded from analysis due to the failure to achieve full equilibration, since the study had to be terminated early. Two patients were unable to complete the final part of the protocol (D disappearance) due to hospital admissions unrelated to the study. The average interdialytic weight gain of the cohort was 1.9 ± 0.6 kg. None of the patients had recent intradialytic hypotension or clinical symptoms to suggest fluid overload. The demographics of the patients are shown in Table 1 .
The accuracy in measurement of deuterium in the vapour phase by the FA-MS is shown in Figure 3 . Pearson's correlation between expected and measured D/H was 0.99 (P < 0.001). The mean D/H values of 556 ppm and 656 ppm standards were measured to be (528 ± 12.8) ppm and (632.6 ± 16.7) ppm and the coefficients of variation were 2.4% and 2.6% respectively.
The ease of breath sample acquisition was closely monitored throughout the study. No difficulty in breath sampling was reported by the patients. The distribution kinetics of the D 2 O following ingestion of D after dialysis was established to determine the TBW PostHD at the end of equilibration. The HDO equilibration (D eqm ) times for the 12 patients are given in Table 1 . The average D eqm time was 1.54 ± 0.23 h. Three distinct phases of breath deuterium content, similar to non-dialysis subjects [4] , are shown in Figure 4A . The clearance of HDO is illustrated in Figure 4B .
The individual TBW values measured by FA-MS after dialysis (TBW PostHD ), pre-dialysis (TBW PreHD ) and following adjustment for interdialytic changes TBW PreHD-adjusted are summarized in Table 1 . TBW PostHD was strongly correlated with TBW PreHD-adjusted (R = 0.99, P < 0.001), with a C.V. of 2.6%. The mean difference between TBW PostHD (50.0 ± 9.3 L) and TBW PreHD-adjusted (50.7 ± 9.0 L) was 0.74 L (SEM 0.35, CI −0.03 to 1.51, P = 0.059). This was compatible with a daily insensible loss of 0.37 L. The Bland and Altman plot demonstrates this agreement with no significant bias between post-dialysis and adjusted predialysis TBW ( Figure 5 ).
Discussion
This paper described a deuterium dilution technique that can be integrated into the current dialysis schedule, allowing determination of post-dialysis TBW by measurement of breath samples 10-15 min before a dialysis session. The FA-MS measurements using prepared deuterium-enriched wa- ter samples indicated an accuracy of ∼2% and has high reproducibility in the measurement of HDO in water vapour, reinforcing our earlier validation work [6] .
Breath sampling is a simple and effortless technique preferred by many patients to blood sampling. Compared to conventional deuterium measurement methods using blood samples, FA-MS has a number of advantages. Firstly, it involved non-invasive breath sampling. Secondly, no adjustment of the difference between plasma water and plasma volume is necessary since the dilution space of HDO in breath is 100% water vapour. In the conventional D dilution technique involving blood or plasma samples, further adjustment of dilution space to plasma water volume is required as an average plasma sample contained only 93% water [10] . Furthermore, FA-MS not only enables on-line assessment of TBW, as with bioelectrical impedance, but it is currently the only near-subject isotopic dilution technique which can measure the absolute TBW rather than relying on regression equations.
This study has established the absorption, equilibration and clearance kinetics of HDO in the water vapour contained in the breath of dialysis patients. The distribution kinetics of HDO in breath following an ingestion of D after dialysis is similar in HD patients to that in healthy subjects [4] . The HDO equilibration time was well within 2 h for all the patients. Although other workers have postulated that the rate of D equilibration may be dependent on body composition, gastrointestinal absorption and cardiac output of the subjects [11, 12] , no obvious related differences have been observed in the HDO kinetic profiles of our patients. One factor that requires consideration when using the deuterium dilution technique is the reduction by 4% in the derived TBW to adjust for the non-aqueous hydrogen exchange between the HDO and the carboxyl and amino groups in body proteins [2] . The exact value for this correction factor is unclear, but is generally thought to be between 2 and 6% as extrapolated from animal studies [13, 14] . In this study, the small difference in absolute postand pre-dialysis TBW over 44 h, which can be accounted for by insensible loss, suggests that this fraction of nonaqueous exchange does not continue to increase after equilibration (i.e. 2 h) and the subsequent prolonged inter-dialytic period.
Assuming that interdialytic fluid losses are accurately measured, we postulated that the TBW measured postdialysis will be highly correlated to the TBW measured at the subsequent pre-dialysis day. We found that the TBW measured after equilibration of HDO in the breath is indeed highly correlated to TBW that was measured pre-dialysis. The correlation is enhanced when the pre-dialysis TBW is adjusted to urine output/44 h and interdialytic weight gain. This is vital, as the breath-sampling regime before dialysis means that it is not necessary for patients to stay behind after dialysis in order to complete the equilibration phase. Additionally, the small difference in the TBW between dialyses can be explained by insensible loss, confirming the ability of FA-MS in tracking fluid status changes between dialysis.
Whilst the number of overall patients, and specifically female subjects, in this study are small, we have demonstrated that the dispersal kinetics and clearance of deuterium are highly reproducible in haemodialysis patients. Additionally, the kinetic profiles are not different between female and male subjects. The main confounder of this approach is the accuracy of interdialytic fluid loss measurements. Accepting that patients do not always remember to collect their urine and the presence of systemic error in weighing of patients (the same scale was used with similar clothing in this study), this sampling regime is still highly reproducible and accurate. A proof of principle study is now required to determine the clinical value of absolute TBW determination in conjunction with a bioelectrical impedance analyser to improve clinical management.
